Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | DGKA | P23743 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6524359 | 0.94 | EPHX2 (0.39) | EPHX2NAAAMEN1KMT2AL3MBTL1 | |
| SCHEMBL6523758 | 0.90 | THRB (0.40) | EPHX2NAAAMEN1KMT2AKDM4E | |
| SCHEMBL6522614 | 0.84 | NPSR1 (0.32) | EPHX2EPHX1 | |
| SCHEMBL6518206 | 0.83 | ALDH1A1 (0.39) | MEN1KMT2AKDM4EHTTTDP1 | |
| SCHEMBL6516577 | 0.83 | MAPT (0.34) | MEN1KMT2AL3MBTL1EPHX1 | |
| SCHEMBL6519432 | 0.82 | FAAH (0.39) | NAAADGKALMNATDP1L3MBTL1 | |
| SCHEMBL6515076 | 0.82 | DGKA (0.38) | EPHX2NAAADGKALMNAFAAH | |
| SCHEMBL6515576 | 0.82 | MAPT (0.32) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL9056869 | 0.82 | THRB (0.43) | EPHX2NAAAMEN1KMT2ADGKA | |
| SCHEMBL6516039 | 0.81 | NAAA (0.49) | EPHX2NAAAMEN1KMT2ADGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | EPHX2 661/4885NAAA 2110/4885MEN1 3248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.